Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | DMAC | GLSI | ||
| Company | Adaptimmune Ther ADR | Diamedica Therapeutics Inc | Greenwich Lifesciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.6600 | 4.04 | 12.97 | ||
| High | 0.6825 | 4.33 | 13.44 | ||
| Low | 0.6309 | 4.03 | 12.51 | ||
| Last | 0.6366 | 4.18 | 12.97 | ||
| Change | -0.0281 | +0.16 | +0.12 | ||
| % Change | -4.23% | +3.98% | +0.93% | ||
| Volume | 789,700 | 1,081,900 | 39,000 | ||
| 20-Day Average Volume | 2,376,750 | 98,355 | 29,175 | ||
| Previous Close | 0.6647 | 4.02 | 12.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.7299 | 4.25 | 13.52 | ||
| 20-Day Raw Stochastic | 22.70% | 46.43% | 37.24% | ||
| 20-Day Relative Strength | 36.71% | 49.10% | 45.37% | ||
| Weighted Alpha | -32.95 | +42.18 | -2.54 | ||
| Today's Opinion | 100% Sell | 40% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 40% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.68% since 11/14/24 | +1.46% since 11/14/24 | -4.56% since 11/14/24 | ||
| Low | 0.5710 on 11/19/24 | 3.92 on 11/18/24 | 12.20 on 11/18/24 | ||
| High | 0.7050 on 11/20/24 | 4.33 on 11/21/24 | 14.31 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -22.72% since 10/21/24 | -2.56% since 10/21/24 | -3.14% since 10/21/24 | ||
| Low | 0.5710 on 11/19/24 | 3.92 on 11/18/24 | 11.89 on 11/05/24 | ||
| High | 0.8600 on 11/06/24 | 4.48 on 10/31/24 | 14.79 on 10/30/24 | ||
| 3-Month | |||||
| %Chg | -46.50% since 08/21/24 | +12.97% since 08/21/24 | -12.36% since 08/21/24 | ||
| Low | 0.5710 on 11/19/24 | 3.74 on 08/22/24 | 11.89 on 11/05/24 | ||
| High | 1.3300 on 08/26/24 | 4.95 on 09/13/24 | 16.50 on 09/09/24 | ||
| 6-Month | |||||
| %Chg | -41.06% since 05/21/24 | +37.50% since 05/21/24 | -4.21% since 05/21/24 | ||
| Low | 0.5710 on 11/19/24 | 2.14 on 06/24/24 | 11.89 on 11/05/24 | ||
| High | 1.4800 on 07/30/24 | 4.95 on 09/13/24 | 18.75 on 06/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 170,085 | 171,899 | 168,913 | ||
| Shares Outstanding, K | 255,883 | 42,761 | 13,145 | ||
| Annual Sales | 60,280,000 | 0 | 0 | ||
| Annual Net Income | -113,870,000 | -19,380,000 | -8,890,000 | ||
| Last Quarter Sales | 40,900,000 | 0 | 0 | ||
| Last Quarter Net Income | -17,620,000 | -6,270,000 | -2,670,000 | ||
| 60-Month Beta | 2.26 | 1.46 | 1.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 11/13/24 | -0.15 on 11/13/24 | -0.20 on 11/14/24 | ||
| Latest Earnings Date | 11/13/24 | 11/13/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||